ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

1-(1-Ethylpiperazin-4-yl)-3-bromoisoquinoline → HCID 22503411、化合物

HRID 1006977
ノート
印刷プレビュー

反応式

HRID 1006977 の反応式
[CH2:1]([O:8][CH2:9][CH2:10][NH:11][C:12](=[O:32])[C:13]1[CH:18]=[CH:17][C:16]([Sn](CCCC)(CCCC)CCCC)=[CH:15][CH:14]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.Br[C:34]1[N:35]=[C:36]([N:44]2[CH2:49][CH2:48][N:47]([CH2:50][CH3:51])[CH2:46][CH2:45]2)[C:37]2[C:42]([CH:43]=1)=[CH:41][CH:40]=[CH:39][CH:38]=2>C1(C)C(C)=CC=CC=1.C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>[CH2:50]([N:47]1[CH2:46][CH2:45][N:44]([C:36]2[C:37]3[C:42](=[CH:41][CH:40]=[CH:39][CH:38]=3)[CH:43]=[C:34]([C:16]3[CH:15]=[CH:14][C:13]([C:12](=[O:32])[NH:11][CH2:10][CH2:9][O:8][CH2:1][C:2]4[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=4)=[CH:18][CH:17]=3)[N:35]=2)[CH2:49][CH2:48]1)[CH3:51]
参加物実験手順後処理出典と根拠反応ノート

参加物

5

反応物 2

HCID 225024471-(1-Ethylpiperazin-4-yl)-3-bromoisoquinolineHCID 22503540HCID 22503540、化合物

生成物 1

HCID 22503411HCID 22503411、化合物収率 22.5%

試薬・触媒・溶媒 2

HCID 178418397HCID 178418397、化合物触媒HCID 7237O-Xylene溶媒

実験手順

N-(2-Benzyloxyethyl)-4-tributylstannylbenzamide (1.23 g) and 3-bromo-1-(4-ethylpiperazin-1-yl)isoquinoline (0.49 g) were heated under reflux in the presence of tetrakistriphenylphosphinepalladium(0) (0.13 g) in xylene in nitrogen atmosphere for 3 hr. After cooling, the reaction solution was filtered and concentrated. The resulting residue was purified by silica gel column chromatography (chloroform/methanol system). The resulting product was dissolved in ethyl acetate and extracted with 2N hydrochloric acid. The aqueous layer was washed with ethyl acetate, adjusted to pH 10 with a 8N aqueous solution of sodium hydroxide, and then extracted with ethyl acetate. The extract was washed with a 10% aqueous solution of sodium carbonate and brine, and dried over magnesium sulfate. The solvent was evaporated, to give 1-(4-ethylpiperazin-1-yl)-3-{4-[N-(2-benzyloxyethyl)carbamoyl]phenyl}isoquinoline (0.17 g) as a pale brown viscous oil.

後処理

  1. temperatureAfter cooling
  2. filtrationthe reaction solution was filtered
  3. concentrationconcentrated
  4. customThe resulting residue was purified by silica gel column chromatography (chloroform/methanol system)
  5. dissolutionThe resulting product was dissolved in ethyl acetate
  6. extractionextracted with 2N hydrochloric acid
  7. washThe aqueous layer was washed with ethyl acetate
  8. extractionextracted with ethyl acetate
  9. washThe extract was washed with a 10% aqueous solution of sodium carbonate and brine
  10. dry with materialdried over magnesium sulfate
  11. customThe solvent was evaporated

出典と根拠

ORDレコード
ord-610755ac53dc40228b09f3a96e96eb95
出典データセット
uspto-grants-2004_09
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US06790844B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート